Boston Scientific To Participate In The 2014 Citi And RBC Capital Markets Global Healthcare Conferences

NATICK, Mass., Feb. 24, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in two conferences, the 2014 Citi Global Healthcare Conference and the RBC Capital Markets Global Healthcare Conference, on February 26, 2014 in New York City.

Dan Brennan, executive vice president and chief financial officer, will participate in a 45-minute question and answer session regarding the company at the Citi Global Healthcare Conference beginning at approximately 10:30 a.m. ET. Mr. Brennan will then participate in a 25-minute question and answer session regarding the company at the RBC Global Healthcare Conference beginning at approximately 3:35 p.m. ET.

A live webcast of each question and answer session will be available to interested parties via the Boston Scientific website.  Webcast registration is available on the Investor Relations section of the website at  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

The respective webcasts are being hosted by Citi and RBC.  The replays will be archived and available at beginning approximately one hour following the completion of the question and answer sessions.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit and connect on Twitter and Facebook.




Denise Kaigler                               

Susie Lisa, CFA

508-650-8330 (office)                    

508- 652-5345 (office)

Corporate Affairs & Communications               

Investor Relations

Boston Scientific Corporation                      

Boston Scientific Corporation                    

SOURCE Boston Scientific Corporation